GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Sprint Bioscience AB (OSTO:SPRINT) » Definitions » Institutional Ownership

Sprint Bioscience AB (OSTO:SPRINT) Institutional Ownership : 0.02% (As of May. 08, 2025)


View and export this data going back to 2014. Start your Free Trial

What is Sprint Bioscience AB Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Sprint Bioscience AB's institutional ownership is 0.02%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Sprint Bioscience AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Sprint Bioscience AB's Float Percentage Of Total Shares Outstanding is 0.00%.


Sprint Bioscience AB Institutional Ownership Historical Data

The historical data trend for Sprint Bioscience AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sprint Bioscience AB Institutional Ownership Chart

Sprint Bioscience AB Historical Data

The historical data trend for Sprint Bioscience AB can be seen below:

2024-06-30 2024-07-31 2024-08-31 2024-09-30 2024-10-31 2024-12-31 2025-01-31 2025-02-28 2025-03-31 2025-04-30
Institutional Ownership 0.01 0.01 0.01 0.03 0.02 0.02 0.02 0.02 0.02 0.02

Sprint Bioscience AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Sprint Bioscience AB Business Description

Traded in Other Exchanges
Address
Halsovagen 7, Floor 8, Elevator A, Novum, Huddinge, SWE, 141 57
Sprint Bioscience AB is a Sweden based company involved in developing drugs focused on cancer and metabolism. The project portfolio of the company includes STK25, VPS34, and PIP4K2.

Sprint Bioscience AB Headlines

No Headlines